Skip to main content
. 2020 Dec 3;51(2):77–87. doi: 10.5051/jpis.2002400120

Table 2. Paired comparisons of parameters measured for the test (PADM) and control (CTG) sides.

Follow-up Clinical parameters Difference tested Mean difference±SD Wilcoxon signed rank test, P value
Baseline RH reduction (mm) Test-control −0.14±0.7 0.277
CAL (mm) Test-control −0.19±0.98 0.233
KT (mm) Test-control −0.07±0.79 0.472
PD (mm) Test-control −0.05±0.51 0.534
RW (mm) Test-control 0.15±0.78 0.283
GT (mm) Test-control −0.02±0.16 0.228
12 months of follow-up RH (mm) Test-control 0.35±0.74 0.014a)
CAL (mm) Test-control 0.39±0.87 0.007a)
KT (mm) Test-control −0.41±0.94 0.190
PD (mm) Test-control −0.01±0.43 0.875
RW (mm) Test-control 0.26±0.67 0.048a)
GT (mm) Test-control −0.68±0.29 <0.001a)
MRC (%) Test-control −12.34±28.2 0.005a)

Values are presented as mean±SD.

PADM: porcine-derived acellular dermal matrix, CTG: connective tissue graft, SD: standard deviation, RH: recession height, CAL: Clinical attachment level, KT: keratinized tissue, PD: probing depth, RW: recession width, GT: gingival thickness, MRC: mean root coverage.

a)Statistically significant difference (P<0.05).